1. Home
  2. PROF vs CVRX Comparison

PROF vs CVRX Comparison

Compare PROF & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Profound Medical Corp.

PROF

Profound Medical Corp.

HOLD

Current Price

$8.24

Market Cap

230.4M

Sector

Health Care

ML Signal

HOLD

Logo CVRx Inc.

CVRX

CVRx Inc.

HOLD

Current Price

$5.19

Market Cap

201.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PROF
CVRX
Founded
N/A
2000
Country
Canada
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
230.4M
201.0M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
PROF
CVRX
Price
$8.24
$5.19
Analyst Decision
Strong Buy
Buy
Analyst Count
1
6
Target Price
$12.00
$13.17
AVG Volume (30 Days)
288.0K
257.5K
Earning Date
03-05-2026
02-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$14,297,000.00
$55,969,000.00
Revenue This Year
$64.23
$11.91
Revenue Next Year
$113.06
$15.28
P/E Ratio
N/A
N/A
Revenue Growth
67.94
18.44
52 Week Low
$3.76
$4.30
52 Week High
$8.95
$18.55

Technical Indicators

Market Signals
Indicator
PROF
CVRX
Relative Strength Index (RSI) 57.22 23.14
Support Level $7.45 $5.34
Resistance Level $8.95 $6.09
Average True Range (ATR) 0.58 0.65
MACD -0.02 -0.21
Stochastic Oscillator 61.13 1.43

Price Performance

Historical Comparison
PROF
CVRX

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

About CVRX CVRx Inc.

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

Share on Social Networks: